Posts matching ‘biomarkers’

This installment of Supplier Spotlight® is on Cancer Genetics, Inc. (CGI, Nasdaq: CGIX) – a leader in enabling precision medicine for oncology from...

To innovate, a variety of expertise, skills, and equipment are required. Things that we don’t necessarily have in-house. So, outsourcing your R&D...

With the rise of next-generation sequencing and the increase of big data, scientists have gained a deeper understanding of various diseases. So it...

The key to fighting chronic diseases is connecting the multitude of scientific and technological advances to diagnostics and therapeutics. Experts...

We previously discussed some of the failures in drug discovery for several chronic diseases. Now, we explore the partnerships that have been...

The BRAIN Initiative sponsored by the NIH has pushed neuroscience and technology to center stage with President Obama supporting advancing...

Imagine this: in a routine blood test, a doctor detects a biomarker that indicates a patient has early-stage pancreatic cancer. A therapeutic is...

Development of clinical diagnostics is a major target for pharmaceutical companies. Drug development is facing new challenges as it becomes more...

Oncology research using genetically engineered mice (GEM) to express oncogenes and model cancers has grown exponentially in the past 30 years...

The Early Drug Development Summit is happening this week in Berlin, Germany, and it brings early drug developers together to discuss maximizing...